PATENT CLAIM ANALYSIS

Application Number: 16196500
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "474000"]

Abstract:
The present invention includes a pharmaceutical composition, and methods of making and using, a pharmaceutical composition comprising one or more thyroid hormone(s) or analogs thereof, wherein a first portion of thyroid hormone(s) is formulated for immediate release and a second portion of thyroid hormone(s) is formulated of modified release, e.g., by forming a drug-resin particle with an ion exchange resin.

Claim (Index 19):
The pharmaceutical composition of  claim 16 , wherein greater than 30%, 40%, 50%, 60%, 70%, or 80% by weight of the first portion of the thyroid hormones is released within the first 45 minutes after the product is introduced into an in vitro dissolution assay, wherein the conditions of the dissolution assay are an initial dissolution medium of 0.1 N HCl, and after 2 hours, the medium is adjusted to a pH of about 6.8, and the dissolution assay is performed using a USP Apparatus 2.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10746386', '12816287', '13844555', '13975725', '14184889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6440641198403176
- 35 USC 102 Novelty (BERT): 0.4950722501935316
- Combined Prediction Score: 0.629164932875639
- Mean Citation Score: 208.947694
- Max Citation Score: 228.03723
- Similarity Product: 170.40646550558208

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test